Atea Pharmaceuticals Stock Price on February 2, 2025
| AVIR Stock | USD 2.99 0.01 0.33% |
Below is the normalized historical share price chart for Atea Pharmaceuticals extending back to October 30, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Atea Pharmaceuticals stands at 2.99, as last reported on the 10th of March, with the highest price reaching 3.05 and the lowest price hitting 2.89 during the day.
If you're considering investing in Atea Stock, it is important to understand the factors that can impact its price. Currently, Atea Pharmaceuticals is slightly risky. Atea Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0235, which signifies that the company had a 0.0235 % return per unit of standard deviation over the last 3 months. We have found twenty-three technical indicators for Atea Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm Atea Pharmaceuticals' risk adjusted performance of (0.04), and Mean Deviation of 1.95 to double-check if the risk estimate we provide is consistent with the expected return of 0.0541%.
At this time, Atea Pharmaceuticals' Total Stockholder Equity is relatively stable compared to the past year. As of 03/10/2025, Common Stock Shares Outstanding is likely to grow to about 86.7 M, while Other Stockholder Equity is likely to drop slightly above 690.5 M. . At this time, Atea Pharmaceuticals' Price Book Value Ratio is relatively stable compared to the past year. As of 03/10/2025, Price To Book Ratio is likely to grow to 0.68, while Price Earnings Ratio is likely to drop (1.76). Atea Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 30th of October 2020 | 200 Day MA 3.4208 | 50 Day MA 3.1526 | Beta 0.183 |
Atea |
Sharpe Ratio = 0.0235
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | AVIR | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.3 actual daily | 20 80% of assets are more volatile |
Expected Return
| 0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Atea Pharmaceuticals is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Atea Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 0.5827 | Enterprise Value Ebitda (260.47) | Price Sales 1.9026 | Shares Float 66.8 M | Wall Street Target Price 7.0667 |
Atea Pharmaceuticals Main Headline on 31st of January 2025
Acquisition by Foster Wayne of 8000 shares of Atea Pharmaceu... by Foster Wayne
Filed transaction by Atea Pharmaceuticals Officer: Evp, Chief Accounting Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Atea Pharmaceuticals Valuation on February 2, 2025
It is possible to determine the worth of Atea Pharmaceuticals on a given historical date. On February 2, 2025 Atea was worth 3.04 at the beginning of the trading date compared to the closed value of 3.06. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Atea Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Atea Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Atea Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Atea Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 3.00 | 3.15 | 2.96 | 2.99 | 498,914 | |
01/31/2025 | 3.04 | 3.09 | 2.97 | 3.06 | 264,000 |
| 2.98 | 3.04 | 2.91 | 2.92 | 382,871 |
| Backtest Atea Pharmaceuticals | | | Atea Pharmaceuticals History | | | Atea Pharmaceuticals Valuation | Previous | Next |
Atea Pharmaceuticals Trading Date Momentum on February 2, 2025
| On February 03 2025 Atea Pharmaceuticals was traded for 2.92 at the closing time. The top price for the day was 3.04 and the lowest listed price was 2.91 . The trading volume for the day was 382.9 K. The trading history from February 3, 2025 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 4.58% . The overall trading delta against the current closing price is 0.98% . |
Atea Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Atea Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Atea Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Atea financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Atea Pharmaceuticals Stock history
Atea Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Atea is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Atea Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Atea Pharmaceuticals stock prices may prove useful in developing a viable investing in Atea Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 84.3 M | 86.7 M | |
| Net Loss | -104.3 M | -99.1 M |
Atea Pharmaceuticals Quarterly Net Working Capital |
|
Atea Pharmaceuticals Stock Technical Analysis
Atea Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Atea Pharmaceuticals Period Price Range
Low | March 10, 2025
| High |
0.00 | 0.00 |
Atea Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Atea Pharmaceuticals March 10, 2025 Market Strength
Market strength indicators help investors to evaluate how Atea Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Atea Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Atea Pharmaceuticals stock market strength indicators, traders can identify Atea Pharmaceuticals entry and exit signals to maximize returns
Atea Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Atea Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Atea Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Atea to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.14) | |||
| Total Risk Alpha | 0.0808 | |||
| Treynor Ratio | (0.37) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Atea Stock Analysis
When running Atea Pharmaceuticals' price analysis, check to measure Atea Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea Pharmaceuticals is operating at the current time. Most of Atea Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Atea Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atea Pharmaceuticals' price. Additionally, you may evaluate how the addition of Atea Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.